Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines (ACCESS-BGR)First published 22/09/2020 Last updated 23/04/2024 EU PAS number: EUPAS37273StudyFinalisedDownload as PDF
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht UniversityNetherlands First published: 01/03/2010Last updated 16/04/2024 InstitutionEducational InstitutionENCePP partner
Netherlands Pharmacovigilance Centre LarebNetherlands First published: 05/02/2010Last updated 19/07/2016 InstitutionNot-for-profitENCePP partner
Pharmacoepidemiology and Pharmacovigilance department, Spanish Agency of medicines and medical devices (AEMPS)Spain First published: 31/07/2014Last updated 18/10/2018 InstitutionRegulatory AuthorityEU Institution/Body/AgencyNot-for-profitENCePP partner
Fundació Institut Català de Farmacologia (FICF)Spain First published: 29/03/2010Last updated 17/09/2019 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of MessinaItaly First published: 29/11/2021Last updated 01/12/2021 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
Bordeaux PharmacoEpi, University of BordeauxFrance First published: 07/02/2023Last updated 08/02/2023 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner
EU Pharmacoepidemiology and Pharmacovigilance (PE&PV) Research NetworkNetherlands First published: 01/02/2024Last updated 12/03/2024 Network